Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil

Transplant International

Volumn 21, Issue 7, 2008, Pages 637-645

  Guba, Markus ^a   Rentsch, Markus ^a   Wimmer, Cosmas D ^a   Uemueksuez, Ayse ^a   Illner, Wolf Dieter ^a   Schönermarck, Ulf ^a   Gottlieb Land, Walter ^b   Jauch, Karl Walter ^a   Arbogast, Helmut ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Calcineurin inhibitor free immunosuppression; ET senior program; Old to old program

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BASILIXIMAB; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; WOUND HEALING;

AGED; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CALCINEURIN; CYTOMEGALOVIRUS INFECTIONS; DELAYED GRAFT FUNCTION; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RECOMBINANT FUSION PROTEINS;

EID: 45749089709     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00658.x     Document Type: Article

References (29)

1. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2001 1-18 : 1.
2. Giessing M, Budde K, Fritsche L, et al. "Old-for-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Eur Urol 2003 44 : 701.
3. de Fijter JW. The impact of age on rejection in kidney transplantation. Drugs Aging 2005 22 : 433.
4. Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005 20 : 34.
5. de Fijter JW, Mallat MJ, Doxiadis II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001 12 : 1538.
6. Fabrizii V, Kovarik J, Bodingbauer M, Kramar R, Horl WH, Winkelmayer WC. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation 2005 80 : 582.
7. Merville P. Combating chronic renal allograft dysfunction: optimal immunosuppressive regimens. Drugs 2005 65 : 615.
8. Land W, Vincenti F. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation 2005 80 : S221.
9. Morales JM, Dominguez-Gil B. Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. J Hypertens 2005 23 : 1609.
10. Jardine AG, Fellstrom B, Logan JO, et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 2005 46 : 529.
11. Grinyo JM, Gil-Vernet S, Seron D, et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 1998 13 : 2601.
12. Arbogast H, Huckelheim H, Schneeberger H, et al. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Clin Transplant 2005 19 : 309.
13. Chappell D, Beiras-Fernandez A, Hammer C, Thein E. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 2006 81 : 552.
14. van Gelder T, Le Meur Y, Shaw LM, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit 2006 28 : 145.
15. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005 18 : 499.
16. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326.
17. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004 78 : 242.
18. Bradley BA. Rejection and recipient age. Transpl Immunol 2002 10 : 125.
19. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Renal transplantation in older people. Lancet 1994 343 : 461.
20. Beiras-Fernandez A, Walther S, Kaczmarek I, et al. In vitro influence of polyclonal anti-thymocyte globulins on leukocyte expression of adhesion molecules. Exp Clin Transplant 2005 3 : 370.
21. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006 21 : 1689.
22. Szwarc I, Garrigue V, Delmas S, Deleuze S, Chong G, Mourad G. Delayed graft function: a frequent but still unsolved problem in renal transplantation. Nephrol Ther 2005 1 : 325.
23. Cicciarelli J, Iwaki Y, Mendez R. The influence of donor age on kidney graft survival in the 1990s. Clin Transpl 1999 13 : 335.
24. Smits JM, Persijn GG, Van Houwelingen HC, Claas FH, Frei U. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002 2 : 664.
25. Voiculescu A, Schlieper G, Hetzel GR, et al. Kidney transplantation in the elderly: age-matching as compared to HLA-matching: a single center experience. Transplantation 2002 73 : 1356.
26. Kovarik JM, Pescovitz MD, Sollinger HW, et al. Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients. Clin Transplant 2001 15 : 123.
27. Vincenti F, Ramos E, Brattstrom C, et al. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 2001 71 : 1282.
28. Boland GJ, Hene RJ, Ververs C, de Haan MA, de Gast GC. Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol 1993 94 : 306.
29. Gonwa TA. Mycophenolate mofetil for maintenance therapy in kidney transplantation. Clin Transplant 1996 10 : 128.